Will weight-loss wonder Ozempic kill Resmed CDI (ASX:RMD) shares?
Luke Laretive
August 29, 2023
The Resmed CDI (ASX: RMD) share price was crushed after
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
The Resmed CDI (ASX: RMD) share price was crushed after
The Cochlear Limited (ASX: COH) share price bounced dramatically higher
S&P/ASX 200 (ASX:XJO) managed a 0.2% gain on Friday, overcoming
ResMed CDI (ASX: RMD) shares are trading down about -11%
The Resmed CDI (ASX:RMD) share price bounced 6.5% higher today
Resmed CDI (ASX:RMD) shares and the Monash IVF Group Ltd
LIVE ASX reporting season coverage is on The Australian Investors
On Wednesday, the Australian share market, or S&P/ASX 200 (INDEXASX:
Here are my three key investor takeaways from a shortened
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.